1 |
Hao XP, Billings SD, Wu FB, et al. Dermatofibrosarcoma protuberans: update on the diagnosis and treatment[J]. J Clin Med, 2020, 9(6): 1752.
|
2 |
Kreicher KL, Kurlander DE, Gittleman HR, et al. Incidence and survival of primary dermatofibrosarcoma protuberans in the United States[J]. Dermatol Surg, 2016, 42(): S24-S31.
|
3 |
Thway K, Noujaim J, Jones RL, et al. Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies[J]. Ann Diagn Pathol, 2016, 25(1): 64-71.
|
4 |
Krewer J, Rolle U, Koscielniak E, et al. Dermatofibrosarcoma protuberans in children and adolescents: primary and relapsed disease, experience of the Cooperative Weichteilsarkomstudiengruppe (CWS)[J]. J Surg Oncol, 2020, 122(2): 263-272.
|
5 |
Iwasaki T, Yamamoto H, Oda Y. Current update on the molecular biology of cutaneous sarcoma: dermatofibrosarcoma protuberans[J]. Curr Treat Options Oncol, 2019, 20(4): 29.
|
6 |
Llombart B, Serra-Guillén C, Monteagudo C, et al. Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management[J]. Semin Diagn Pathol, 2013, 30(1): 13-28.
|
7 |
Li Y, Wang C, Yang K, et al. Clinical features of dermatofibrosarcoma protuberans and risk factors for local recurrence after Mohs micrographic surgery[J]. J Am Acad Dermatol, 2020, 82(5): 1219-1221.
|
8 |
王传彬, 韦超, 李乃玉, 等. 隆突性皮肤纤维肉瘤的CT和MRI表现[J]. 中国医学装备, 2021, 18(4): 58-61.
|
9 |
Beaman FD, Kransdorf MJ, Andrews TR, et al. Superficial soft-tissue masses: analysis, diagnosis, and differential considerations[J]. RadioGraphics, 2007, 27(2): 509-523.
|
10 |
Millare GG, Guha-Thakurta N, Sturgis EM, et al. Imaging findings of head and neck dermatofibrosarcoma protuberans[J]. AJNR Am J Neuroradiol, 2014, 35(2): 373-378.
|
11 |
Choong P, Lindsay D, Khoo M, et al. Dermatofibrosarcoma protuberans: the diagnosis of high-grade fibrosarcomatous transformation[J]. Skeletal Radiol, 2021, 50(4): 789-799.
|
12 |
Chen J, Zhou XB, Sun D, et al. Preoperative 3-dimensional reconstruction of dermatofibrosarcoma protuberans[J]. Dermatol Surg, 2019, 45(6): 848-852.
|
13 |
Zhou X, Sun D, Liu Y, et al. Dermatofibrosarcoma protuberans: our 10-year experience on 80 patients[J]. J Dermatolog Treat, 2020, 31(6): 554-558.
|
14 |
Bergin P, Rezaei S, Lau Q, et al. Dermatofibrosarcoma protuberans, magnetic resonance imaging and pathological correlation[J]. Australas Radiol, 2007, 51 (S1): B64-B66.
|
15 |
Al-Tamimi A, Zaheer S, Pierce CK, et al. Recurrent dermatofibrosarcoma protuberans of the shoulder with rare distant abdominal metastasis detected by fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT)[J]. Sultan Qaboos Univ Med J, 2012, 12(3): 371-374.
|
16 |
Hakozaki M, Yamada H, Hasegawa O, et al. Radiologic-pathologic correlations of fibrosarcomatous dermatofibrosarcoma protuberans with various histological features on enhanced MRI and PET/MRI[J]. Clin Nucl Med, 2016, 41(3): 241-243.
|
17 |
罗振东, 陈卫国, 郑彤, 等. MRI诊断隆凸性皮肤纤维肉瘤[J]. 中国医学影像技术, 2011, 27(8): 1672-1675.
|
18 |
Xu S, Zhao L, Wang J. Atrophic dermatofibrosarcoma protuberans: a clinicopathological study of 16 cases[J]. Pathology, 2019, 51(6): 615-620.
|
19 |
Allen A, Ahn C, Sangüeza OP. Dermatofibrosarcoma protuberans[J]. Dermatol Clin, 2019, 37(4): 483-488.
|
20 |
Saiag P, Grob JJ, Lebbe C, et al. Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline[J]. Eur J Cancer, 2015, 51(17): 2604-2608.
|
21 |
Ugurel S, Kortmann RD, Mohr P, et al. S1 guidelines for dermatofibrosarcoma protuberans (DFSP): update 2018[J]. J Dtsch Dermatol Ges, 2019, 17(6): 663-668.
|
22 |
Lowe GC, Onajin O, Baum CL, et al. A comparison of Mohs micrographic surgery and wide local excision for treatment of dermatofibrosarcoma protuberans with long-term follow-up: the mayo clinic experience[J]. Dermatol Surg, 2017, 43(1): 98-106.
|
23 |
Ugurel S, Mentzel T, Utikal J, et al. Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase Ⅱ DeCOG trial with long-term follow-up[J]. Clin Cancer Res, 2014, 20(2): 499-510.
|
24 |
Navarrete-Dechent C, Mori S, Barker CA, et al. Imatinib treatment for locally advanced or metastatic dermatofibrosarcoma protuberans: a systematic review[J]. JAMA Dermatol, 2019, 155(3): 361-369.
|